Key result
Diabetes mellitus did not affect long-term all-cause mortality but increased the overall incidence of major adverse cardiovascular and cerebrovascular events in patients with ischemic heart failure undergoing CABG.
Why the study?
Few studies have examined the impact of diabetes mellitus on long-term outcomes after surgical revascularization in patients with ischemic heart failure, and existing results remain controversial.
Does diabetes mellitus increase the risk of long-term adverse outcomes in patients with ischemic heart failure undergoing CABG?
Cohort (n=346)
No
Does diabetes mellitus increase the risk of long-term adverse outcomes in patients with ischemic heart failure undergoing CABG?
In patients with ischemic heart failure undergoing CABG, diabetes mellitus is associated with a higher risk of long-term major adverse cardiovascular and cerebrovascular events, though it does not significantly impact all-cause mortality.
Answers are grounded in this paper and cite their sources.
DM associated with higher long-term MACCE but not mortality after CABG in ischemic HF; leaves open whether targeted strategies improve outcomes.
BACKGROUND: Diabetes mellitus (DM) is an important risk factor in the long-term outcomes of surgical revascularization. However, few studies have focused on patients with ischemic heart failure (IHF) and DM, and the results are controversial. This study aimed to evaluate the effect of DM on the long-term outcomes of IHF patients undergoing coronary artery bypass grafting (CABG). METHODS: In this propensity-matched study, data of IHF patients who underwent CABG in our hospital from January 2007 to December 2017 were analyzed. With a mean 73-month follow-up time, the patients were divided into two groups according to whether they had DM. The primary endpoint was all-cause death, and the secondary endpoint was a composite of all-cause death, stroke, recurrent myocardial infarction, and revascularization. RESULTS: There was no significant difference in all-cause mortality between the two groups (5.8% vs. 4.1%, P = 0.216). The incidence of main adverse cardiovascular and cerebrovascular events (MACCE) in the secondary endpoint was significantly higher in the DM group than that in the non-DM group (10.4% vs. 8.1%, P = 0.023). CONCLUSIONS: DM can negatively affect the long-term outcomes of IHF patients undergoing CABG by significantly increasing the overall incidence of MACCE, though the long-term survival does not show a significant difference between the DM and non-DM patients.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) conducted a cohort in Ischemic heart failure (n=346). Diabetes mellitus vs. Non-diabetes mellitus was evaluated on All-cause death (p=0.216). Diabetes mellitus did not affect long-term all-cause mortality but increased the overall incidence of major adverse cardiovascular and cerebrovascular events in patients with ischemic heart failure undergoing CABG.
Synapse has enriched 10 related papers. Consider them for comparative context: